Alyeska Investment Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,667	Closed	-$600K	–	448
2018 Q3	$600K	Buy	+1,667	New	+$600K	0.01%	343
2014 Q4	–	Sell	-32	Closed	-$150K	–	516
2014 Q3	$150K	Buy	+32	New	+$150K	﹤0.01%	352